IPRATROPIUM BROMIDE

IPRATROPIUM BROMIDE was reported 36016 times

IPRATROPIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 71 0.7396
1 APPENDICOLITH 282 0.7287
2 ANTACID THERAPY 91 0.7000
3 SLEEP DISORDER THERAPY 131 0.6616
4 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 114 0.6369
5 TOTAL LUNG CAPACITY INCREASED 169 0.6213
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 283 0.5411
7 HYPER IGE SYNDROME 53 0.4649
8 ANALGESIC THERAPY 147 0.4579
9 DRUG THERAPY 140 0.4130
10 BRONCHIAL NEOPLASM 50 0.3676
11 ANTICOAGULANT THERAPY 90 0.3169
12 PROLONGED EXPIRATION 74 0.2824
13 MALIGNANT MELANOMA STAGE 0 56 0.2679
14 CONGENITAL HIATUS HERNIA 56 0.2456
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 180 0.1942
16 BRONCHIAL HAEMORRHAGE 51 0.1635
17 RESPIRATORY GAS EXCHANGE DISORDER 60 0.1617
18 RIB DEFORMITY 41 0.1614
19 BACTEROIDES INFECTION 40 0.1533
20 NASAL TURBINATE HYPERTROPHY 57 0.1512
21 VENTRICULAR FAILURE 46 0.1470
22 REVERSIBLE AIRWAYS OBSTRUCTION 73 0.1437
23 ENDOMETRIAL ABLATION 50 0.1401
24 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 43 0.1239
25 OBSTRUCTIVE AIRWAYS DISORDER 1368 0.1229
26 TOTAL LUNG CAPACITY DECREASED 170 0.1064
27 OBSTRUCTIVE SLEEP APNOEA SYNDROME 139 0.0953
28 BREAST CONSERVING SURGERY 47 0.0918
29 HYPERPHOSPHATAEMIA 196 0.0911
30 EOSINOPHIL COUNT ABNORMAL 67 0.0897
31 VENOUS PRESSURE JUGULAR INCREASED 32 0.0882
32 STATUS ASTHMATICUS 41 0.0869
33 RHONCHI 119 0.0861
34 LUNG HYPERINFLATION 69 0.0802
35 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 51 0.0794
36 RESTRICTIVE PULMONARY DISEASE 93 0.0794
37 MYOGLOBIN BLOOD INCREASED 120 0.0784
38 FORCED VITAL CAPACITY DECREASED 51 0.0781
39 BRONCHIAL HYPERREACTIVITY 92 0.0765
40 VITAL CAPACITY DECREASED 34 0.0759
41 BLOOD PHOSPHORUS INCREASED 205 0.0750
42 BRONCHIECTASIS 497 0.0737
43 DIAPHRAGMATIC DISORDER 56 0.0732
44 OESOPHAGEAL SPASM 129 0.0700
45 BRONCHIAL WALL THICKENING 49 0.0682
46 LUNG OPACITY 176 0.0667
47 NASAL OBSTRUCTION 122 0.0650
48 FORCED EXPIRATORY VOLUME DECREASED 176 0.0621
49 DYSPNOEA EXACERBATED 30 0.0583
50 RALES 337 0.0580
51 BREATH SOUNDS ABNORMAL 274 0.0555
52 PULMONARY FUNCTION TEST ABNORMAL 83 0.0532
53 RHINITIS ALLERGIC 228 0.0512
54 SPUTUM DISCOLOURED 484 0.0510
55 PLEURITIC PAIN 137 0.0496
56 BRAIN NATRIURETIC PEPTIDE INCREASED 150 0.0486
57 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 818 0.0481
58 FULL BLOOD COUNT ABNORMAL 490 0.0463
59 WHEEZING 2691 0.0453
60 PCO2 INCREASED 32 0.0449
61 NASAL POLYPS 217 0.0440
62 ASTHMATIC CRISIS 147 0.0402
63 POLYCYSTIC OVARIES 62 0.0399
64 BRONCHIAL DISORDER 62 0.0398
65 NASAL DISCHARGE DISCOLOURATION 54 0.0391
66 PRODUCT DELIVERY MECHANISM ISSUE 207 0.0385
67 PUPILS UNEQUAL 44 0.0384
68 BLOOD IMMUNOGLOBULIN E INCREASED 93 0.0384
69 UPPER AIRWAY OBSTRUCTION 34 0.0383
70 AORTIC STENOSIS 133 0.0382
71 PULMONARY FUNCTION TEST DECREASED 167 0.0381
72 PLANTAR FASCIITIS 125 0.0372
73 BLOOD COUNT ABNORMAL 563 0.0371
74 ASTHMA 4095 0.0362
75 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1882 0.0360
76 JAUNDICE CHOLESTATIC 124 0.0351
77 SARCOIDOSIS 165 0.0347
78 SPUTUM RETENTION 33 0.0333
79 IRON DEFICIENCY 147 0.0327
80 OESOPHAGEAL PAIN 129 0.0326
81 APPENDICITIS 302 0.0323
82 BLOOD URIC ACID INCREASED 184 0.0318
83 LUNG CONSOLIDATION 89 0.0318
84 COR PULMONALE 30 0.0314
85 MYCOBACTERIUM AVIUM COMPLEX INFECTION 84 0.0313
86 KYPHOSIS 55 0.0311
87 RESPIRATORY SYMPTOM 88 0.0309
88 PO2 DECREASED 35 0.0304
89 SINUS PAIN 71 0.0304
90 EMPHYSEMA 306 0.0303
91 RECTAL PROLAPSE 36 0.0298
92 CARDIAC MURMUR 256 0.0296
93 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 148 0.0292
94 UPPER-AIRWAY COUGH SYNDROME 239 0.0290
95 HYPOMANIA 106 0.0288
96 LYMPHOEDEMA 197 0.0285
97 VENTRICULAR FIBRILLATION 301 0.0271
98 HYPOPHOSPHATAEMIA 200 0.0270
99 THROAT CLEARING 101 0.0269
100 HYPOVENTILATION 87 0.0267
101 HYPERCAPNIA 80 0.0265
102 LEFT VENTRICULAR HYPERTROPHY 111 0.0259
103 LEFT ATRIAL DILATATION 33 0.0259
104 BLOOD TEST ABNORMAL 352 0.0250
105 CARBON DIOXIDE INCREASED 34 0.0249
106 RHINITIS 201 0.0249
107 BLOOD CALCIUM INCREASED 217 0.0247
108 MYASTHENIA GRAVIS 199 0.0246
109 ISCHAEMIC CARDIOMYOPATHY 74 0.0241
110 PRODUCTIVE COUGH 1152 0.0241
111 ASPIRATION 264 0.0241
112 RESPIRATION ABNORMAL 165 0.0239
113 CHEST X-RAY ABNORMAL 72 0.0235
114 CARDIOGENIC SHOCK 335 0.0233
115 TERMINAL INSOMNIA 41 0.0231
116 EOSINOPHILIA 405 0.0231
117 DYSPNOEA EXERTIONAL 833 0.0221
118 INFUSION SITE DISCHARGE 38 0.0217
119 BLOOD PH DECREASED 37 0.0216
120 PNEUMONIA VIRAL 69 0.0216
121 SLEEP APNOEA SYNDROME 411 0.0215
122 DYSLIPIDAEMIA 105 0.0207
123 HYPERLIPIDAEMIA 247 0.0206
124 LOBAR PNEUMONIA 38 0.0205
125 GRANULOMA 70 0.0202
126 INCREASED UPPER AIRWAY SECRETION 103 0.0200
127 STAPHYLOCOCCUS TEST POSITIVE 42 0.0199
128 BUNDLE BRANCH BLOCK LEFT 84 0.0198
129 BENIGN PROSTATIC HYPERPLASIA 100 0.0193
130 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 923 0.0192
131 INFUSION SITE BRUISING 41 0.0190
132 EOSINOPHIL COUNT INCREASED 158 0.0189
133 ATELECTASIS 179 0.0185
134 DEPRESSIVE SYMPTOM 65 0.0184
135 BRONCHOSPASM 263 0.0184
136 TROPONIN INCREASED 140 0.0184
137 PULMONARY MASS 272 0.0182
138 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1297 0.0182
139 CHRONIC SINUSITIS 67 0.0178
140 LUNG NEOPLASM 76 0.0178
141 SECRETION DISCHARGE 222 0.0177
142 SEASONAL ALLERGY 246 0.0174
143 RESPIRATORY RATE INCREASED 154 0.0173
144 LOWER RESPIRATORY TRACT INFECTION 788 0.0173
145 RESPIRATORY ACIDOSIS 68 0.0173
146 ORTHOPNOEA 55 0.0173
147 OBSTRUCTION 68 0.0170
148 PHARYNGEAL ERYTHEMA 36 0.0170
149 BRONCHITIS CHRONIC 41 0.0168
150 BACTERIAL INFECTION 309 0.0165
151 PNEUMONIA STAPHYLOCOCCAL 32 0.0162
152 INFUSION SITE PRURITUS 51 0.0161
153 MULTIPLE ALLERGIES 125 0.0159
154 MIDDLE INSOMNIA 295 0.0158
155 INCREASED BRONCHIAL SECRETION 40 0.0156
156 HYPERPARATHYROIDISM SECONDARY 38 0.0152
157 VENTRICULAR HYPERTROPHY 38 0.0151
158 INFUSION SITE HAEMORRHAGE 49 0.0149
159 TACHYPNOEA 201 0.0148
160 HAEMOPTYSIS 410 0.0147
161 PAINFUL RESPIRATION 35 0.0145
162 LACTOSE INTOLERANCE 37 0.0144
163 SENSATION OF FOREIGN BODY 121 0.0143
164 EXOSTOSIS 127 0.0139
165 CORONARY ARTERY DISEASE 421 0.0139
166 TRICUSPID VALVE INCOMPETENCE 110 0.0138
167 CREPITATIONS 41 0.0138
168 PNEUMOTHORAX 218 0.0137
169 BRONCHOPNEUMONIA 47 0.0137
170 HYPOXIA 478 0.0136
171 MULTIPLE ORGAN DYSFUNCTION SYNDROME 374 0.0132
172 BLOOD CHLORIDE DECREASED 34 0.0132
173 CHEST DISCOMFORT 1349 0.0132
174 RESPIRATORY DISORDER 394 0.0132
175 ORAL CANDIDIASIS 173 0.0131
176 ACUTE RESPIRATORY FAILURE 251 0.0130
177 BRONCHITIS 960 0.0130
178 UPPER RESPIRATORY TRACT INFECTION 599 0.0130
179 RHINOVIRUS INFECTION 50 0.0128
180 AORTIC ARTERIOSCLEROSIS 33 0.0128
181 PARANASAL SINUS DISCOMFORT 48 0.0127
182 DIASTOLIC DYSFUNCTION 39 0.0126
183 SENSITIVITY TO WEATHER CHANGE 66 0.0125
184 APPETITE DISORDER 82 0.0124
185 TOXIC EPIDERMAL NECROLYSIS 187 0.0123
186 THERAPEUTIC AGENT TOXICITY 41 0.0123
187 OXYGEN SATURATION DECREASED 687 0.0122
188 CANDIDIASIS 49 0.0122
189 RESPIRATORY DISTRESS 337 0.0122
190 RESPIRATORY TRACT INFECTION 315 0.0121
191 ASCITES 355 0.0121
192 NASAL CONGESTION 704 0.0120
193 CARDIOMEGALY 147 0.0119
194 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 65 0.0119
195 PULMONARY FIBROSIS 229 0.0119
196 MITRAL VALVE INCOMPETENCE 135 0.0119
197 LEFT VENTRICULAR FAILURE 41 0.0119
198 FLANK PAIN 110 0.0117
199 SINUS TACHYCARDIA 163 0.0115
200 HIATUS HERNIA 148 0.0114
201 PULMONARY PAIN 33 0.0113
202 AORTIC VALVE INCOMPETENCE 48 0.0113
203 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 193 0.0112
204 NEPHROGENIC ANAEMIA 52 0.0112
205 LUNG DISORDER 546 0.0111
206 DIVERTICULUM 79 0.0111
207 COUGH 3117 0.0111
208 RESPIRATORY FAILURE 810 0.0111
209 LUNG INFECTION 171 0.0110
210 GOUT 195 0.0109
211 PULMONARY CONGESTION 143 0.0108
212 DYSPNOEA 6130 0.0108
213 SPINAL OSTEOARTHRITIS 95 0.0108
214 RENAL FAILURE CHRONIC 83 0.0108
215 INFUSION SITE ERYTHEMA 90 0.0107
216 GASTROOESOPHAGEAL REFLUX DISEASE 843 0.0105
217 FIBROMYALGIA 253 0.0104
218 HEPARIN-INDUCED THROMBOCYTOPENIA 51 0.0103
219 ACUTE CORONARY SYNDROME 85 0.0103
220 AORTIC ANEURYSM 78 0.0102
221 END STAGE RENAL DISEASE 186 0.0102
222 HYPERCHOLESTEROLAEMIA 98 0.0101
223 SUPRAVENTRICULAR EXTRASYSTOLES 34 0.0101
224 PSEUDOMONAS INFECTION 86 0.0100
225 RESPIRATORY TRACT CONGESTION 158 0.0099
226 PNEUMONIA 3215 0.0099
227 AFFECTIVE DISORDER 78 0.0099
228 DYSPHONIA 575 0.0098
229 HYPONATRAEMIA 551 0.0098
230 DUODENITIS 30 0.0098
231 FRUSTRATION TOLERANCE DECREASED 79 0.0098
232 PULMONARY HYPERTENSION 203 0.0097
233 SCHIZOPHRENIA 118 0.0097
234 SINUS DISORDER 192 0.0097
235 INTERNATIONAL NORMALISED RATIO DECREASED 39 0.0096
236 NEURALGIA 234 0.0096
237 IDIOPATHIC PULMONARY FIBROSIS 38 0.0096
238 CONGESTIVE CARDIOMYOPATHY 40 0.0096
239 HAEMORRHAGIC ANAEMIA 42 0.0095
240 TRANSAMINASES INCREASED 211 0.0095
241 CAROTID ARTERY STENOSIS 33 0.0094
242 INFUSION SITE SWELLING 59 0.0094
243 CYANOSIS 145 0.0092
244 ARTERIOSCLEROSIS CORONARY ARTERY 61 0.0092
245 ECONOMIC PROBLEM 138 0.0091
246 SINUS CONGESTION 123 0.0091
247 PLEURAL EFFUSION 553 0.0091
248 OEDEMA PERIPHERAL 1101 0.0090
249 PROTHROMBIN TIME PROLONGED 54 0.0090
250 SNORING 34 0.0090
251 ULCER 143 0.0090
252 PERIPHERAL VASCULAR DISORDER 46 0.0089
253 ANGINA UNSTABLE 58 0.0089
254 LUNG INFILTRATION 78 0.0088
255 DECREASED ACTIVITY 95 0.0088
256 OSTEOPENIA 133 0.0088
257 RESPIRATORY SYNCYTIAL VIRUS INFECTION 76 0.0087
258 PNEUMONITIS 236 0.0087
259 MULTIPLE INJURIES 54 0.0086
260 GOITRE 35 0.0085
261 SINUSITIS 867 0.0085
262 IRON DEFICIENCY ANAEMIA 78 0.0084
263 CYSTITIS 267 0.0084
264 MUSCULOSKELETAL CHEST PAIN 129 0.0083
265 BUNDLE BRANCH BLOCK RIGHT 38 0.0083
266 CARDIOMYOPATHY 122 0.0082
267 WALKING AID USER 54 0.0082
268 RENAL CYST 65 0.0082
269 SUPRAVENTRICULAR TACHYCARDIA 78 0.0081
270 ATRIAL FIBRILLATION 787 0.0081
271 BLOOD ALBUMIN DECREASED 64 0.0081
272 OESOPHAGEAL DISORDER 31 0.0080
273 INFUSION SITE PAIN 103 0.0080
274 LIVER FUNCTION TEST INCREASED 171 0.0080
275 RENAL FAILURE ACUTE 337 0.0079
276 CANDIDA INFECTION 134 0.0079
277 PNEUMONIA BACTERIAL 72 0.0078
278 ILEUS PARALYTIC 35 0.0078
279 FLUID RETENTION 397 0.0078
280 RHINORRHOEA 501 0.0077
281 BODY TEMPERATURE DECREASED 76 0.0077
282 ODYNOPHAGIA 46 0.0077
283 ATRIAL FLUTTER 61 0.0076
284 MYOCARDIAL ISCHAEMIA 87 0.0076
285 OROPHARYNGEAL DISCOMFORT 69 0.0076
286 SPINAL COLUMN STENOSIS 36 0.0076
287 MICTURITION URGENCY 87 0.0076
288 ASPHYXIA 62 0.0076
289 PHARYNGITIS 94 0.0076
290 MALNUTRITION 84 0.0075
291 CHOKING SENSATION 41 0.0074
292 EXERCISE TOLERANCE DECREASED 42 0.0073
293 PULMONARY OEDEMA 324 0.0072
294 GENERAL PHYSICAL HEALTH DETERIORATION 837 0.0072
295 SNEEZING 161 0.0072
296 CARDIAC FAILURE CONGESTIVE 572 0.0071
297 HYPERVENTILATION 41 0.0071
298 MULTI-ORGAN FAILURE 122 0.0070
299 INTERNATIONAL NORMALISED RATIO INCREASED 201 0.0070
300 CARDIAC FAILURE CHRONIC 30 0.0070
301 RESTLESS LEGS SYNDROME 128 0.0070
302 VENTRICULAR EXTRASYSTOLES 73 0.0070
303 BLOOD BILIRUBIN INCREASED 189 0.0070
304 CHOLELITHIASIS 229 0.0070
305 BLOOD PRESSURE SYSTOLIC INCREASED 135 0.0069
306 ATRIOVENTRICULAR BLOCK FIRST DEGREE 30 0.0069
307 INFLUENZA 771 0.0069
308 THROAT IRRITATION 309 0.0069
309 ANGINA PECTORIS 197 0.0069
310 HEART RATE ABNORMAL 38 0.0068
311 CATHETERISATION CARDIAC 30 0.0068
312 STRESS CARDIOMYOPATHY 39 0.0067
313 SEPSIS 747 0.0067
314 LUNG NEOPLASM MALIGNANT 274 0.0067
315 HYPOVOLAEMIA 39 0.0067
316 BLOOD CREATININE INCREASED 433 0.0066
317 SCOLIOSIS 41 0.0066
318 TYPE 2 DIABETES MELLITUS 221 0.0066
319 LARYNGEAL OEDEMA 40 0.0065
320 DIABETIC NEUROPATHY 32 0.0065
321 APHONIA 90 0.0064
322 EXTRASYSTOLES 45 0.0064
323 BLOOD CHOLESTEROL INCREASED 299 0.0064
324 OBESITY 101 0.0063
325 CYSTIC FIBROSIS 35 0.0063
326 PULMONARY EMBOLISM 599 0.0063
327 VENTRICULAR TACHYCARDIA 104 0.0063
328 DRY THROAT 64 0.0063
329 INTERVERTEBRAL DISC DEGENERATION 58 0.0063
330 BLOOD LACTIC ACID INCREASED 33 0.0063
331 VIRAL INFECTION 207 0.0062
332 UROSEPSIS 57 0.0062
333 INTESTINAL ISCHAEMIA 34 0.0062
334 DRY MOUTH 496 0.0061
335 DIABETES MELLITUS 465 0.0061
336 SKIN LACERATION 66 0.0061
337 ACUTE PULMONARY OEDEMA 34 0.0061
338 BLOOD UREA INCREASED 101 0.0060
339 UNRESPONSIVE TO STIMULI 155 0.0060
340 SLEEP DISORDER 421 0.0060
341 PNEUMONIA ASPIRATION 149 0.0060
342 OROPHARYNGEAL PAIN 552 0.0060
343 COVID-19 PNEUMONIA 70 0.0059
344 HEPATOTOXICITY 132 0.0059
345 TRANSIENT ISCHAEMIC ATTACK 200 0.0059
346 TOOTH ABSCESS 60 0.0059
347 HAEMATOMA 152 0.0059
348 HYPOTHYROIDISM 187 0.0058
349 OSTEOARTHRITIS 247 0.0058
350 RENAL TUBULAR NECROSIS 57 0.0058
351 TACHYCARDIA 514 0.0058
352 COLITIS ISCHAEMIC 39 0.0058
353 ELECTROCARDIOGRAM ABNORMAL 45 0.0057
354 HYPERKALAEMIA 201 0.0057
355 LACTIC ACIDOSIS 185 0.0057
356 HYPERGLYCAEMIA 208 0.0057
357 ANKLE FRACTURE 88 0.0057
358 SPINAL COMPRESSION FRACTURE 47 0.0057
359 LEFT VENTRICULAR DYSFUNCTION 38 0.0057
360 JOINT INJURY 121 0.0057
361 OSTEOPOROSIS 233 0.0057
362 PHARMACEUTICAL PRODUCT COMPLAINT 147 0.0057
363 SHOCK HAEMORRHAGIC 46 0.0056
364 BODY HEIGHT DECREASED 60 0.0056
365 HAEMATOCRIT DECREASED 111 0.0056
366 NASAL DRYNESS 35 0.0056
367 HEART RATE INCREASED 553 0.0056
368 CLOSTRIDIUM DIFFICILE COLITIS 59 0.0056
369 PSYCHOTIC DISORDER 164 0.0055
370 ARTERIOSCLEROSIS 52 0.0055
371 PULMONARY THROMBOSIS 60 0.0055
372 OCULAR DISCOMFORT 61 0.0054
373 ELECTROLYTE IMBALANCE 63 0.0054
374 BLOOD SODIUM DECREASED 102 0.0054
375 PRODUCT ADMINISTRATION ERROR 109 0.0054
376 ABSCESS 86 0.0054
377 ABDOMINAL DISTENSION 562 0.0054
378 EAR INFECTION 143 0.0054
379 NEUTROPHIL COUNT INCREASED 55 0.0054
380 DERMATITIS CONTACT 61 0.0053
381 CONCOMITANT DISEASE AGGRAVATED 33 0.0053
382 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 47 0.0053
383 INSURANCE ISSUE 81 0.0053
384 AGITATION 388 0.0053
385 DECUBITUS ULCER 43 0.0053
386 APNOEA 41 0.0053
387 CHOKING 102 0.0052
388 CHEST PAIN 966 0.0052
389 NASOPHARYNGITIS 961 0.0052
390 PHARYNGEAL SWELLING 51 0.0052
391 GASTROENTERITIS VIRAL 94 0.0052
392 LEUKOCYTOSIS 94 0.0052
393 ANAEMIA 990 0.0052
394 ORAL DISORDER 38 0.0052
395 HYPOKALAEMIA 239 0.0052
396 HEART RATE IRREGULAR 117 0.0052
397 FOREIGN BODY SENSATION IN EYES 33 0.0052
398 BLOOD PRESSURE DIASTOLIC DECREASED 38 0.0051
399 PERICARDIAL EFFUSION 119 0.0051
400 CARDIAC DISORDER 481 0.0051
401 LOWER GASTROINTESTINAL HAEMORRHAGE 38 0.0051
402 UPPER GASTROINTESTINAL HAEMORRHAGE 86 0.0051
403 URINARY INCONTINENCE 151 0.0051
404 MYOPATHY 44 0.0051
405 ACUTE MYOCARDIAL INFARCTION 150 0.0051
406 HAND FRACTURE 36 0.0051
407 LARGE INTESTINE POLYP 35 0.0050
408 NASAL DISCOMFORT 40 0.0050
409 COAGULOPATHY 84 0.0050
410 VITAMIN D DEFICIENCY 49 0.0050
411 RIB FRACTURE 103 0.0050
412 TINNITUS 230 0.0050
413 HAEMODIALYSIS 42 0.0050
414 RIGHT VENTRICULAR FAILURE 35 0.0050
415 GLAUCOMA 96 0.0050
416 ANOREXIA 64 0.0050
417 ECCHYMOSIS 34 0.0050
418 EJECTION FRACTION DECREASED 77 0.0049
419 OEDEMA 268 0.0049
420 FOOD ALLERGY 38 0.0049
421 THROMBOSIS 396 0.0049
422 BRONCHOPULMONARY ASPERGILLOSIS 38 0.0049
423 FLUID OVERLOAD 71 0.0049
424 ASPERGILLUS INFECTION 32 0.0049
425 URINE OUTPUT DECREASED 42 0.0048
426 WEIGHT FLUCTUATION 50 0.0048
427 LIGAMENT SPRAIN 47 0.0047
428 PRESYNCOPE 115 0.0047
429 CARDIO-RESPIRATORY ARREST 197 0.0047
430 TREMOR 780 0.0047
431 HYPERTENSION 990 0.0047
432 CONDITION AGGRAVATED 1420 0.0047
433 MUSCULOSKELETAL STIFFNESS 409 0.0047
434 SWELLING 436 0.0047
435 MIGRAINE 444 0.0046
436 CONSTIPATION 1011 0.0046
437 BLOOD POTASSIUM INCREASED 75 0.0046
438 DYSURIA 170 0.0046
439 BREAST MASS 31 0.0046
440 CHOLESTASIS 88 0.0046
441 ARRHYTHMIA 216 0.0046
442 TONGUE DISORDER 33 0.0046
443 CHRONIC KIDNEY DISEASE 345 0.0045
444 SUDDEN DEATH 48 0.0045
445 HEPATOMEGALY 44 0.0045
446 ABDOMINAL PAIN 1041 0.0045
447 ASPARTATE AMINOTRANSFERASE INCREASED 237 0.0045
448 BODY TEMPERATURE INCREASED 91 0.0045
449 HAEMORRHOIDS 87 0.0045
450 DISABILITY 88 0.0044
451 SKIN LESION 122 0.0044
452 URINARY RETENTION 148 0.0044
453 CARDIAC FAILURE 356 0.0044
454 PHARYNGEAL OEDEMA 68 0.0044
455 BIPOLAR DISORDER 48 0.0044
456 CATARACT 262 0.0044
457 POLYURIA 36 0.0044
458 FEEDING DISORDER 89 0.0044
459 INFECTION 635 0.0044
460 CARDIOVASCULAR DISORDER 111 0.0044
461 MELAENA 96 0.0044
462 HALLUCINATION 328 0.0043
463 PRODUCT ADMINISTRATION INTERRUPTED 34 0.0043
464 MUSCLE DISORDER 35 0.0043
465 INJURY 303 0.0043
466 EPISTAXIS 322 0.0043
467 DELIRIUM 148 0.0043
468 DUODENAL ULCER 30 0.0042
469 DENTAL CARIES 47 0.0042
470 ACUTE RESPIRATORY DISTRESS SYNDROME 75 0.0042
471 FUNGAL INFECTION 141 0.0042
472 BACK INJURY 46 0.0042
473 PULMONARY HAEMORRHAGE 33 0.0042
474 RENAL FAILURE 559 0.0042
475 CONTUSION 404 0.0042
476 WEIGHT DECREASED 1167 0.0042
477 THROAT TIGHTNESS 113 0.0042
478 TOOTH INFECTION 55 0.0042
479 HYPOMAGNESAEMIA 58 0.0042
480 TENDONITIS 64 0.0041
481 BLOOD IRON DECREASED 49 0.0041
482 ANAPHYLACTIC REACTION 228 0.0041
483 PYREXIA 1426 0.0041
484 GASTROENTERITIS 60 0.0041
485 ORAL PAIN 92 0.0041
486 GASTRITIS 108 0.0041
487 EMBOLISM 34 0.0041
488 BRADYCARDIA 217 0.0041
489 HYPERHIDROSIS 523 0.0041
490 ILLNESS 418 0.0041
491 STOMATITIS 246 0.0041
492 MYDRIASIS 52 0.0040
493 MYOCARDIAL INFARCTION 700 0.0040
494 WRIST FRACTURE 48 0.0040
495 BLOOD CALCIUM DECREASED 45 0.0040
496 HAEMATURIA 137 0.0040
497 SMALL INTESTINAL OBSTRUCTION 49 0.0040
498 TENDON RUPTURE 49 0.0040
499 STENT PLACEMENT 32 0.0040
500 EAR PAIN 77 0.0040
501 GENERALISED OEDEMA 49 0.0040
502 BURSITIS 48 0.0040
503 POOR QUALITY SLEEP 85 0.0039
504 HYPOTENSION 792 0.0039
505 HAEMATEMESIS 100 0.0039
506 OESOPHAGITIS 43 0.0039
507 MALAISE 1724 0.0039
508 CELLULITIS 198 0.0039
509 MENTAL IMPAIRMENT 95 0.0039
510 URINARY TRACT INFECTION 665 0.0039
511 BLOOD PRESSURE INCREASED 596 0.0039
512 ESCHERICHIA INFECTION 32 0.0039
513 MENTAL STATUS CHANGES 108 0.0039
514 ANXIETY 1103 0.0039
515 MUSCULOSKELETAL PAIN 203 0.0039
516 ADRENAL INSUFFICIENCY 47 0.0039
517 BLOOD ALKALINE PHOSPHATASE INCREASED 96 0.0039
518 CARDIAC ARREST 319 0.0039
519 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 30 0.0039
520 BLOOD POTASSIUM DECREASED 116 0.0039
521 MACULAR DEGENERATION 46 0.0038
522 HEART RATE DECREASED 135 0.0038
523 INTERVERTEBRAL DISC PROTRUSION 84 0.0038
524 TENDERNESS 40 0.0038
525 SEPTIC SHOCK 167 0.0038
526 BLOOD PRESSURE FLUCTUATION 92 0.0038
527 EYE DISORDER 126 0.0038
528 WHITE BLOOD CELL COUNT INCREASED 147 0.0038
529 LIMB INJURY 104 0.0038
530 LACERATION 36 0.0038
531 BLOOD PRESSURE ABNORMAL 76 0.0038
532 ARTERIAL OCCLUSIVE DISEASE 30 0.0038
533 CLOSTRIDIUM DIFFICILE INFECTION 83 0.0038
534 ACUTE KIDNEY INJURY 580 0.0038
535 NOCTURIA 46 0.0038
536 PHARYNGITIS STREPTOCOCCAL 41 0.0038
537 HYPERSOMNIA 108 0.0038
538 SCIATICA 60 0.0038
539 HEPATIC ENCEPHALOPATHY 35 0.0037
540 BLOOD PRESSURE DECREASED 249 0.0037
541 INTENTIONAL PRODUCT MISUSE 328 0.0037
542 ECZEMA 196 0.0037
543 ASTHENIA 1404 0.0037
544 GASTROINTESTINAL HAEMORRHAGE 312 0.0037
545 PURPURA 33 0.0037
546 METABOLIC ACIDOSIS 119 0.0037
547 MASS 52 0.0037
548 HYPOKINESIA 54 0.0037
549 FALL 1233 0.0037
550 EAR DISCOMFORT 38 0.0037
551 ILEUS 46 0.0037
552 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 38 0.0037
553 HYPOCALCAEMIA 70 0.0037
554 STAPHYLOCOCCAL INFECTION 122 0.0037
555 DIVERTICULITIS 102 0.0037
556 MYOSITIS 33 0.0037
557 PALLOR 100 0.0037
558 TOXIC SKIN ERUPTION 37 0.0037
559 POOR VENOUS ACCESS 38 0.0037
560 ORAL DISCOMFORT 51 0.0037
561 RETCHING 78 0.0037
562 DERMATITIS ALLERGIC 46 0.0037
563 VOMITING 1713 0.0036
564 NEPHROPATHY 34 0.0036
565 GASTRIC ULCER 69 0.0036
566 SYNCOPE 363 0.0036
567 BLADDER DISORDER 36 0.0036
568 ANHEDONIA 95 0.0036
569 HEMIPARESIS 61 0.0036
570 FAECES DISCOLOURED 78 0.0036
571 FEELING COLD 100 0.0036
572 RESPIRATORY ARREST 99 0.0036
573 SPINAL DISORDER 34 0.0036
574 DEPRESSION 816 0.0036
575 PALPITATIONS 420 0.0036
576 DYSPHAGIA 340 0.0036
577 ROTATOR CUFF SYNDROME 46 0.0036
578 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
579 EYE PAIN 202 0.0036
580 VITREOUS FLOATERS 35 0.0036
581 WEIGHT INCREASED 797 0.0036
582 DIARRHOEA HAEMORRHAGIC 33 0.0035
583 HEPATOCELLULAR INJURY 50 0.0035
584 PULMONARY ARTERIAL HYPERTENSION 51 0.0035
585 SINUS BRADYCARDIA 34 0.0035
586 EYE PRURITUS 118 0.0035
587 NECK PAIN 196 0.0035
588 SOMNOLENCE 705 0.0035
589 SPLENOMEGALY 41 0.0035
590 HERPES ZOSTER 201 0.0035
591 RECTAL HAEMORRHAGE 150 0.0035
592 BRAIN INJURY 35 0.0035
593 POST PROCEDURAL COMPLICATION 67 0.0035
594 TEMPERATURE INTOLERANCE 36 0.0035
595 WOUND INFECTION 38 0.0035
596 DRUG INTOLERANCE 335 0.0035
597 SPEECH DISORDER 181 0.0035
598 THERAPEUTIC RESPONSE DECREASED 209 0.0034
599 ANAL INCONTINENCE 31 0.0034
600 DIABETES MELLITUS INADEQUATE CONTROL 61 0.0034
601 LACRIMATION INCREASED 104 0.0034
602 DRUG INTERACTION 545 0.0034
603 DISORIENTATION 136 0.0034
604 FOOT FRACTURE 65 0.0034
605 CONFUSIONAL STATE 554 0.0034
606 MUSCULOSKELETAL DISCOMFORT 59 0.0034
607 DEHYDRATION 457 0.0034
608 SCAB 39 0.0034
609 IMMUNE SYSTEM DISORDER 45 0.0034
610 ANAPHYLACTIC SHOCK 88 0.0034
611 CONJUNCTIVITIS 63 0.0034
612 SWOLLEN TONGUE 106 0.0034
613 ABDOMINAL PAIN UPPER 696 0.0034
614 LIVER FUNCTION TEST ABNORMAL 98 0.0034
615 ARTHRITIS 265 0.0034
616 HAEMOGLOBIN DECREASED 345 0.0034
617 HYPOTHERMIA 34 0.0034
618 BONE DISORDER 61 0.0033
619 DYSPEPSIA 329 0.0033
620 HEPATIC STEATOSIS 62 0.0033
621 SALIVARY HYPERSECRETION 33 0.0033
622 INSOMNIA 874 0.0033
623 RESTLESSNESS 120 0.0033
624 BLOOD CREATINE PHOSPHOKINASE INCREASED 94 0.0033
625 BACK PAIN 757 0.0033
626 PANCYTOPENIA 182 0.0033
627 MEDICATION ERROR 181 0.0033
628 CHILLS 381 0.0032
629 URTICARIA 543 0.0032
630 DEPRESSED MOOD 171 0.0032
631 COLD SWEAT 57 0.0032
632 PRODUCT DOSE OMISSION ISSUE 951 0.0032
633 JOINT DISLOCATION 34 0.0032
634 TREATMENT NONCOMPLIANCE 175 0.0032
635 VISION BLURRED 438 0.0032
636 DEPRESSED LEVEL OF CONSCIOUSNESS 126 0.0032
637 MOVEMENT DISORDER 102 0.0032
638 MUSCLE SPASMS 582 0.0032
639 RASH PAPULAR 71 0.0032
640 C-REACTIVE PROTEIN INCREASED 115 0.0032
641 ORTHOSTATIC HYPOTENSION 55 0.0032
642 SPINAL PAIN 37 0.0032
643 HERNIA 61 0.0032
644 SCAR 54 0.0032
645 HEPATIC ENZYME INCREASED 215 0.0032
646 RED BLOOD CELL COUNT DECREASED 90 0.0031
647 DEEP VEIN THROMBOSIS 204 0.0031
648 HYPOGLYCAEMIA 152 0.0031
649 DIZZINESS 1558 0.0031
650 HYPERSENSITIVITY 577 0.0031
651 SHOCK 71 0.0031
652 CARPAL TUNNEL SYNDROME 43 0.0031
653 IMPAIRED QUALITY OF LIFE 44 0.0031
654 TRANSFUSION 32 0.0031
655 DYSSTASIA 89 0.0030
656 NO THERAPEUTIC RESPONSE 37 0.0030
657 DIALYSIS 43 0.0030
658 INCONTINENCE 32 0.0030
659 SWELLING FACE 197 0.0030
660 LETHARGY 174 0.0030
661 CHOLECYSTITIS 36 0.0030
662 MYOCLONUS 36 0.0030
663 LOCALISED INFECTION 73 0.0030
664 HEPATIC FAILURE 91 0.0030
665 EYE INFECTION 34 0.0030
666 IMPAIRED GASTRIC EMPTYING 41 0.0030
667 TOOTHACHE 54 0.0030
668 GAMMA-GLUTAMYLTRANSFERASE INCREASED 66 0.0030
669 FEELING ABNORMAL 712 0.0030
670 SKIN DISORDER 99 0.0030
671 RASH MACULO-PAPULAR 66 0.0030
672 DRUG PRESCRIBING ERROR 57 0.0030
673 DRUG LEVEL INCREASED 49 0.0030
674 HYPOACUSIS 127 0.0029
675 RASH ERYTHEMATOUS 141 0.0029
676 AMNESIA 191 0.0029
677 FATIGUE 2285 0.0029
678 HYPOPHAGIA 75 0.0029
679 CORONARY ARTERY OCCLUSION 40 0.0029
680 HYPERCALCAEMIA 36 0.0029
681 PLATELET COUNT INCREASED 38 0.0029
682 SKIN ULCER 75 0.0029
683 BEDRIDDEN 38 0.0029
684 FOOT DEFORMITY 32 0.0029
685 ACTIVITIES OF DAILY LIVING IMPAIRED 57 0.0029
686 CIRCULATORY COLLAPSE 49 0.0029
687 HEAD INJURY 91 0.0029
688 PERIPHERAL SWELLING 442 0.0029
689 UPPER LIMB FRACTURE 57 0.0029
690 RESPIRATORY DEPRESSION 35 0.0029
691 KIDNEY INFECTION 56 0.0029
692 SKIN INFECTION 32 0.0028
693 MUSCULAR WEAKNESS 324 0.0028
694 PARANOIA 49 0.0028
695 INTERSTITIAL LUNG DISEASE 137 0.0028
696 MENTAL DISORDER 123 0.0028
697 DISCOMFORT 172 0.0028
698 THROMBOCYTOPENIA 315 0.0028
699 BLOOD GLUCOSE ABNORMAL 52 0.0028
700 TOOTH FRACTURE 31 0.0028
701 ELECTROCARDIOGRAM QT PROLONGED 101 0.0028
702 SPINAL FRACTURE 56 0.0028
703 WOUND 78 0.0028
704 VERTIGO 170 0.0028
705 FEAR 75 0.0028
706 PRODUCT QUALITY ISSUE 378 0.0028
707 BACTERAEMIA 33 0.0028
708 TUBULOINTERSTITIAL NEPHRITIS 52 0.0028
709 LYMPHOCYTE COUNT DECREASED 49 0.0028
710 ENCEPHALOPATHY 68 0.0028
711 PERIPHERAL COLDNESS 38 0.0028
712 DYSARTHRIA 104 0.0028
713 NERVOUSNESS 144 0.0028
714 ABASIA 68 0.0027
715 HALLUCINATION, VISUAL 58 0.0027
716 GALLBLADDER DISORDER 49 0.0027
717 SENSORY DISTURBANCE 44 0.0027
718 RENAL IMPAIRMENT 230 0.0027
719 POLLAKIURIA 114 0.0027
720 PAIN IN EXTREMITY 804 0.0027
721 PAIN IN JAW 77 0.0027
722 FLATULENCE 154 0.0027
723 ACCIDENTAL UNDERDOSE 39 0.0027
724 STEVENS-JOHNSON SYNDROME 60 0.0027
725 HYPERTHYROIDISM 39 0.0027
726 HEADACHE 1686 0.0027
727 AGEUSIA 67 0.0027
728 DIARRHOEA 1733 0.0027
729 LYMPHADENOPATHY 95 0.0027
730 LIVER DISORDER 118 0.0027
731 MUSCLE TIGHTNESS 43 0.0027
732 DRUG TOXICITY 36 0.0026
733 JOINT SWELLING 317 0.0026
734 COMA 125 0.0026
735 DECREASED APPETITE 608 0.0026
736 ABDOMINAL PAIN LOWER 66 0.0026
737 HEAD DISCOMFORT 46 0.0026
738 GAIT DISTURBANCE 497 0.0026
739 INFLAMMATION 134 0.0026
740 NAUSEA 2040 0.0026
741 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 464 0.0026
742 FEELING JITTERY 49 0.0026
743 THERAPEUTIC PRODUCT EFFECT DECREASED 115 0.0026
744 GINGIVAL BLEEDING 35 0.0026
745 INTESTINAL OBSTRUCTION 96 0.0025
746 OSTEOMYELITIS 46 0.0025
747 GASTROINTESTINAL DISORDER 226 0.0025
748 PRODUCT PRESCRIBING ERROR 60 0.0025
749 COVID-19 438 0.0025
750 HIP FRACTURE 80 0.0025
751 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
752 NEPHROLITHIASIS 114 0.0025
753 PAIN 1526 0.0025
754 APHASIA 75 0.0025
755 PRODUCT USE IN UNAPPROVED INDICATION 613 0.0025
756 PSYCHOMOTOR HYPERACTIVITY 41 0.0025
757 DEVICE RELATED INFECTION 38 0.0025
758 LIP SWELLING 82 0.0025
759 ALANINE AMINOTRANSFERASE INCREASED 151 0.0025
760 NODULE 32 0.0024
761 NIGHT SWEATS 79 0.0024
762 HOSPITALISATION 376 0.0024
763 BALANCE DISORDER 211 0.0024
764 DYSKINESIA 99 0.0024
765 LOSS OF CONSCIOUSNESS 312 0.0024
766 CONVULSION 139 0.0024
767 OCULAR HYPERAEMIA 115 0.0024
768 HEPATITIS 62 0.0024
769 MOBILITY DECREASED 174 0.0024
770 ILL-DEFINED DISORDER 147 0.0024
771 ANOSMIA 35 0.0024
772 CYST 30 0.0024
773 DEVICE OCCLUSION 34 0.0024
774 JAUNDICE 65 0.0024
775 HOT FLUSH 182 0.0024
776 DRUG ADMINISTRATION ERROR 74 0.0024
777 THERAPY NON-RESPONDER 108 0.0024
778 RASH MACULAR 84 0.0024
779 EXPOSURE VIA SKIN CONTACT 62 0.0024
780 PRURITUS 916 0.0024
781 TOOTH DISORDER 53 0.0024
782 RASH PRURITIC 129 0.0024
783 LABORATORY TEST ABNORMAL 70 0.0024
784 SKIN DISCOLOURATION 109 0.0024
785 DEAFNESS 62 0.0024
786 BLOOD URINE PRESENT 45 0.0024
787 GAIT INABILITY 79 0.0024
788 INTENTIONAL DOSE OMISSION 67 0.0023
789 EMOTIONAL DISORDER 72 0.0023
790 IRRITABLE BOWEL SYNDROME 50 0.0023
791 MOUTH ULCERATION 49 0.0023
792 AGRANULOCYTOSIS 43 0.0023
793 DIPLOPIA 60 0.0023
794 DEVICE DEFECTIVE 40 0.0023
795 PARALYSIS 33 0.0023
796 BRAIN FOG 36 0.0023
797 RENAL DISORDER 107 0.0023
798 FEELING HOT 140 0.0023
799 HYPOAESTHESIA 341 0.0023
800 PANIC ATTACK 83 0.0023
801 BACK DISORDER 37 0.0023
802 INFLUENZA LIKE ILLNESS 187 0.0023
803 THYROID DISORDER 35 0.0023
804 CEREBROVASCULAR ACCIDENT 384 0.0023
805 ANGIOEDEMA 100 0.0023
806 MYALGIA 382 0.0022
807 HAEMATOCHEZIA 124 0.0022
808 SUBDURAL HAEMATOMA 32 0.0022
809 PRURITUS GENERALISED 48 0.0022
810 FEBRILE NEUTROPENIA 147 0.0022
811 BURNING SENSATION 155 0.0022
812 EYE SWELLING 82 0.0022
813 DRY EYE 110 0.0022
814 FACE OEDEMA 37 0.0022
815 MEMORY IMPAIRMENT 301 0.0022
816 EYE IRRITATION 126 0.0022
817 ARTHRALGIA 910 0.0022
818 RENAL INJURY 65 0.0022
819 NEUROPATHY PERIPHERAL 208 0.0022
820 SKIN CANCER 47 0.0022
821 PANCREATITIS ACUTE 49 0.0022
822 FEMUR FRACTURE 67 0.0022
823 PARAESTHESIA 340 0.0022
824 PRODUCT USE COMPLAINT 34 0.0022
825 ROAD TRAFFIC ACCIDENT 90 0.0021
826 COORDINATION ABNORMAL 30 0.0021
827 NERVOUS SYSTEM DISORDER 67 0.0021
828 UNEVALUABLE EVENT 162 0.0021
829 THIRST 38 0.0021
830 ABDOMINAL DISCOMFORT 356 0.0021
831 NIGHTMARE 73 0.0021
832 DRUG EFFECT DECREASED 113 0.0021
833 DRUG INEFFECTIVE 2757 0.0021
834 KNEE ARTHROPLASTY 44 0.0021
835 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0021
836 PHOTOPHOBIA 39 0.0021
837 RASH 902 0.0021
838 GASTRIC DISORDER 71 0.0021
839 SURGERY 121 0.0021
840 DYSGEUSIA 153 0.0021
841 GLOSSODYNIA 46 0.0021
842 DISTURBANCE IN ATTENTION 110 0.0020
843 MUSCLE TWITCHING 47 0.0020
844 INFUSION RELATED REACTION 135 0.0020
845 OFF LABEL USE 1781 0.0020
846 BLISTER 114 0.0020
847 ISCHAEMIC STROKE 36 0.0020
848 BONE PAIN 118 0.0020
849 RHABDOMYOLYSIS 84 0.0020
850 COLON CANCER 30 0.0020
851 PRODUCT DOSE OMISSION 131 0.0020
852 PROTEINURIA 38 0.0020
853 ALTERED STATE OF CONSCIOUSNESS 43 0.0020
854 IMPAIRED HEALING 65 0.0020
855 COLITIS 75 0.0020
856 INTENTIONAL PRODUCT USE ISSUE 173 0.0020
857 HAEMORRHAGE 206 0.0020
858 CONTRAINDICATED PRODUCT ADMINISTERED 59 0.0019
859 SEIZURE 225 0.0019
860 MUCOSAL INFLAMMATION 51 0.0019
861 OSTEONECROSIS OF JAW 48 0.0019
862 DEMENTIA 54 0.0019
863 EATING DISORDER 41 0.0019
864 BLOOD GLUCOSE DECREASED 92 0.0019
865 LIMB DISCOMFORT 59 0.0019
866 COGNITIVE DISORDER 89 0.0019
867 CHROMATURIA 43 0.0019
868 ERYTHEMA 391 0.0019
869 DEVICE USE ISSUE 33 0.0019
870 MANIA 31 0.0019
871 PLATELET COUNT DECREASED 200 0.0019
872 BLOOD TRIGLYCERIDES INCREASED 33 0.0019
873 LEUKOPENIA 93 0.0019
874 PANCREATITIS 98 0.0019
875 DRUG EFFECT INCOMPLETE 67 0.0018
876 NEUTROPENIA 250 0.0018
877 LOCAL SWELLING 32 0.0018
878 FLUSHING 186 0.0018
879 CEREBRAL INFARCTION 44 0.0018
880 VISUAL IMPAIRMENT 223 0.0018
881 RASH GENERALISED 46 0.0018
882 LOWER LIMB FRACTURE 34 0.0018
883 DEVICE DELIVERY SYSTEM ISSUE 48 0.0018
884 TOOTH LOSS 36 0.0017
885 PRODUCT USE ISSUE 325 0.0017
886 ARTHROPATHY 96 0.0017
887 NEUTROPHIL COUNT DECREASED 70 0.0017
888 PROCEDURAL PAIN 47 0.0017
889 ORAL HERPES 33 0.0017
890 DEATH 1441 0.0017
891 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 43 0.0017
892 PRODUCT AVAILABILITY ISSUE 38 0.0017
893 ABNORMAL BEHAVIOUR 66 0.0017
894 DIABETIC KETOACIDOSIS 40 0.0017
895 CEREBRAL HAEMORRHAGE 59 0.0016
896 PERITONITIS 34 0.0016
897 IRRITABILITY 98 0.0016
898 THERAPEUTIC RESPONSE SHORTENED 54 0.0016
899 TASTE DISORDER 33 0.0016
900 VISUAL ACUITY REDUCED 54 0.0016
901 DEVICE MALFUNCTION 113 0.0016
902 THERAPEUTIC RESPONSE UNEXPECTED 72 0.0016
903 ADVERSE DRUG REACTION 144 0.0016
904 JOINT STIFFNESS 42 0.0016
905 FULL BLOOD COUNT DECREASED 32 0.0016
906 BONE MARROW FAILURE 32 0.0016
907 EMOTIONAL DISTRESS 190 0.0016
908 RHEUMATOID ARTHRITIS 177 0.0016
909 PRODUCT DOSE OMISSION IN ERROR 44 0.0016
910 INTENTIONAL DRUG MISUSE 32 0.0015
911 DISEASE PROGRESSION 180 0.0015
912 SKIN EXFOLIATION 128 0.0015
913 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 51 0.0015
914 BLOOD GLUCOSE INCREASED 284 0.0015
915 WHITE BLOOD CELL COUNT DECREASED 159 0.0015
916 CRYING 53 0.0015
917 BLINDNESS 59 0.0014
918 MOOD SWINGS 46 0.0014
919 AGGRESSION 72 0.0014
920 INCORRECT DOSE ADMINISTERED BY DEVICE 37 0.0014
921 WRONG TECHNIQUE IN DRUG USAGE PROCESS 51 0.0014
922 ANGER 47 0.0014
923 OSTEONECROSIS 45 0.0014
924 ACCIDENTAL OVERDOSE 50 0.0014
925 EXPIRED PRODUCT ADMINISTERED 45 0.0014
926 UNDERDOSE 98 0.0013
927 EPILEPSY 41 0.0013
928 SEDATION 35 0.0013
929 DRY SKIN 178 0.0013
930 DISEASE RECURRENCE 63 0.0013
931 INCORRECT DOSE ADMINISTERED 302 0.0013
932 INCORRECT ROUTE OF DRUG ADMINISTRATION 47 0.0013
933 NEEDLE ISSUE 38 0.0013
934 PRODUCT COMPLAINT 33 0.0013
935 FREQUENT BOWEL MOVEMENTS 35 0.0013
936 ERECTILE DYSFUNCTION 33 0.0013
937 TARDIVE DYSKINESIA 36 0.0013
938 GLYCOSYLATED HAEMOGLOBIN INCREASED 32 0.0013
939 ABNORMAL DREAMS 35 0.0013
940 EXTRAPYRAMIDAL DISORDER 31 0.0012
941 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 58 0.0012
942 PLASMA CELL MYELOMA 48 0.0012
943 MALIGNANT NEOPLASM PROGRESSION 125 0.0012
944 THERAPY INTERRUPTED 87 0.0012
945 OVERDOSE 257 0.0012
946 NO ADVERSE EVENT 215 0.0012
947 NEOPLASM MALIGNANT 79 0.0012
948 ADVERSE EVENT 109 0.0012
949 DEVICE ISSUE 105 0.0012
950 EXTRA DOSE ADMINISTERED 47 0.0012
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 81 0.0011
952 BONE DENSITY DECREASED 34 0.0011
953 DEVICE USE ERROR 37 0.0011
954 SUICIDAL IDEATION 97 0.0011
955 DRUG DOSE OMISSION 175 0.0011
956 INJECTION SITE RASH 32 0.0010
957 DEVICE LEAKAGE 45 0.0010
958 HEPATIC FUNCTION ABNORMAL 38 0.0010
959 DRUG EXPOSURE DURING PREGNANCY 34 0.0010
960 MULTIPLE SCLEROSIS 47 0.0010
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 196 0.0010
962 ALOPECIA 188 0.0010
963 MATERNAL EXPOSURE DURING PREGNANCY 85 0.0010
964 THERAPY CESSATION 48 0.0009
965 INJECTION SITE PRURITUS 62 0.0009
966 INJECTION SITE PAIN 281 0.0009
967 BREAST CANCER 85 0.0009
968 SUICIDE ATTEMPT 55 0.0009
969 TOXICITY TO VARIOUS AGENTS 149 0.0009
970 INJECTION SITE SWELLING 67 0.0009
971 PROSTATE CANCER 70 0.0009
972 INJECTION SITE MASS 32 0.0009
973 DEVICE DISLOCATION 37 0.0009
974 INTENTIONAL OVERDOSE 53 0.0008
975 ACCIDENTAL EXPOSURE TO PRODUCT 85 0.0008
976 INJECTION SITE ERYTHEMA 99 0.0008
977 WITHDRAWAL SYNDROME 33 0.0008
978 PSORIASIS 97 0.0007
979 COLITIS ULCERATIVE 33 0.0007
980 EXPOSURE DURING PREGNANCY 45 0.0007
981 INJECTION SITE BRUISING 57 0.0007
982 INJECTION SITE REACTION 49 0.0007
983 DRUG WITHDRAWAL SYNDROME 61 0.0007
984 INJECTION SITE HAEMORRHAGE 55 0.0007
985 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 37 0.0007
986 DERMATITIS ATOPIC 32 0.0006
987 TREATMENT FAILURE 47 0.0006
988 PRODUCT SUBSTITUTION ISSUE 32 0.0006
989 DRUG DEPENDENCE 85 0.0005
990 DRUG ABUSE 42 0.0005
991 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
992 ACNE 37 0.0005
993 DRUG DOSE OMISSION BY DEVICE 37 0.0005
994 PRODUCT STORAGE ERROR 31 0.0004